If you’re searching for the best cancer hospital in Germany, you’ll quickly notice the problem: Germany doesn’t have “one” perfect option. It has a dense network of leading German cancer clinics, and the right choice depends on your needs.<ref>1</ref> The factors can be the speed of diagnosis, access to subspecialists, complex cancer surgery, advanced immunotherapy, or a second opinion that’s backed by a tumor board and deep experience.

A major quality signal is certification: the German Cancer Society reports more than 2,000 Certified Cancer Centres nationwide.<ref>1</ref> It is an indicator of structured processes, cross-specialty collaboration, and audited standards.<ref>2</ref>

This ranking is for people who don’t want to pick a clinic based on name recognition alone. It highlights what distinguishes true leaders. I’ll walk through the top 10 with a patient-first lens. Then move on to distinguishing features to determine which center is best for what situations, what it’s known for, and when it makes sense to prioritize one clinic over another.

{{ text-with-contact-button__language=en }}

Best Hospitals for Cancer Treatment in Germany

The table below highlights the top-rated hospitals in a clear, comparable format. To help you evaluate German cancer clinics quickly and objectively, each entry includes the hospital name, its primary oncology unit or specialty center, and a set of scoring metrics that reflect key patient priorities.

Rank	Hospital	Primary cancer unit*	AiroScore	UserScore
1	University Hospital Charité Berlin	Charité Comprehensive Cancer Center	5.0	3.33
2	University Hospital Heidelberg	National Center for Tumor Diseases	4.95	3.13
3	University Hospital Ludwig-Maximilians Munich	Comprehensive Cancer Center Munich	4.9	4.45
4	University Hospital Cologne	Center for Integrated Oncology	4.85	3.03
5	University Hospital Rechts der Isar Munich	Comprehensive Cancer Center Munich	4.95	3.22
6	University Hospital Essen	West German Cancer Center	4.9	2.8
7	University Hospital Hamburg-Eppendorf	University Cancer Center Hamburg	4.85	3.27
8	University Hospital Freiburg	Comprehensive Cancer Center Freiburg	4.9	3.35
9	University Hospital Frankfurt am Main	University Center for Tumour Diseases	4.95	2.71
10	Hannover Medical School Hospital	Comprehensive Cancer Center Hannover	4.95	3.3

* Highlighted only the interdisciplinary cancer-oriented units.

{{ btn-select-a-hospital__language=en&variant=2 }}

Details of the Best German Cancer Clinics

Finding the best hospital for cancer treatment in Germany can be overwhelming: many leading centers offer comparable technologies, multidisciplinary teams, and internationally recognized standards of care. The section below provides a quick, at-a-glance key to what differentiates each facility.

Top 5 Oncological Clinics in Germany

Check the first five hospitals in our rending throug ha deepre review. Such clinics typically demonstrate better treatment outcomes, have higher patient volumes, offer treatments for rare cancers, conduct more research, and receive more reliable feedback from patients.

University Hospital Charité Berlin

University Hospital Charité Berlin is often the starting point for distinguishing “well-known” from genuinely top-performing care among the best German cancer clinics. The hospital is ranked among the top 25 general hospitals in Germany, in 1st place.

What makes oncology care feel different in practice is the way decisions are formalized through the Charité Comprehensive Cancer Center.<ref>3</ref> Instead of a single department “owning” your case, treatment is routinely shaped in tumor conferences that bring together large, cross-specialty teams.<ref>4</ref> The centre reports that in 2022, it produced more than 21,000 individualized treatment plans for more than 14,000 patients, with 200+ experienced oncologists involved.<ref>3</ref> This is a concrete indicator of the number of treated cases being managed through a structured, interdisciplinary process.

That structure matters most for complex decisions. In cases where the most suitable plan depends on sequencing surgery, systemic therapy, and radiation, and where molecular profiling can change the entire strategy.<ref>5</ref> The University Hospital Charité setup aligns with the principles of modern precision oncology, where tumor profiling and a molecular tumor board discussion are integral to translating data into a personalized treatment plan.<ref>6</ref> The hospital case is expected to follow evidence-based guidelines rather than individual preference.

On the technology side, the radiation oncology unit covers modern external-beam techniques. It is also known for a specific particle-therapy success story: radiotherapy & proton therapy for ocular tumors delivered through the long-running collaboration, BerlinProtonen.<ref>7</ref>

If you’re comparing hard outcomes, the ocular proton centre reports that eye cancer can be controlled in 96% of patients, a finding confirmed by peer-reviewed studies.<ref>8</ref> There is a useful survival statistics-adjacent context when discussing real-world results in a defined indication (ocular melanoma).

University Hospital Heidelberg

In Germany, University Hospital Heidelberg consistently stands out as a top performer in cancer care. Many consider it the best cancer hospital in the country, and for good reason.<ref>9</ref> The institution operates through the National Center for Tumor Diseases (NCT) in Heidelberg, an innovative facility that bridges the gap between university medicine and translational research.<ref>10</ref> This “under one roof” approach makes the treatment journey far more cohesive for patients, especially when multiple specialties must collaborate effectively.

Heidelberg isn’t just known for its reputation; it backs it up with impressive numbers. The NCT serves approximately 16,000 patients each year, hosts approximately 20 interdisciplinary tumor boards weekly, and conducts nearly 400 oncology clinical studies simultaneously.<ref>11</ref>

The oncology centre has been certified by the German Cancer Society (DKG) since 2018 and receives continuous re-certification.<ref>12</ref> Patients gain access to the latest therapies and cutting-edge research, ensuring they receive the best care possible, even when standard treatment options have been exhausted.

University Hospital Heidelberg is recognized for its advanced systemic therapy programs, particularly in immunotherapy.<ref>13</ref> The NCT emphasizes this area as a key focus, actively researching immune checkpoint inhibitors and other innovative therapies. If you find yourself facing a complex case or seeking a second oncological opinion, Heidelberg is often the go-to choice for patients.

University Hospital Ludwig-Maximilians Munich

At University Hospital Ludwig-Maximilians (LMU) Munich, the oncology ecosystem centers on the Comprehensive Cancer Center Munich.<ref>14</ref> It is a joint structure with the university hospitals in Munich that, since 2014, has been recognized by German Cancer Aid as an Oncological Center of Excellence and is part of a nationwide network of 14 such centers.<ref>15</ref>

LMU is often recognized as one of the best hospitals for cancer in Germany, and there's a good reason for that. It operates like a high-volume oncology center, successfully managing complex cases and continuously validating its decisions with real-world evidence.

An excellent example is the Munich Molecular Tumor Board, which began in 2016 as part of a precision oncology program. In an analysis of the first 1,000 consecutive cases from January 2016 to March 2020, 914 patients underwent comprehensive genomic profiling, achieving an 88% technical success rate. Notably, 41% of these cases revealed genomic findings that led to therapy recommendations.<ref>16</ref>

LMU Munich is particularly well-known for its access to clinical trials, especially for patients with advanced or previously treated diseases.<ref>17</ref> The CCC Munich aims to quickly translate innovative diagnostic and therapeutic strategies into early clinical studies, ensuring that patients not only learn about new options but also have the opportunity to be evaluated for them within the same system.

The hospital has a strong clinical trials infrastructure. It covers a wide range of studies, from first-in-human Phase 1 trials to Phase 4 studies. The infrastructure includes specialized research teams and an early clinical trial unit.<ref>18</ref> This setup helps bring new therapies to patients quickly.

University Hospital Ludwig-Maximilians is also a partner site in the German Cancer Consortium (DKTK).<ref>19</ref> This network focuses on accelerating the adoption of new advances in cancer prevention, diagnosis, and treatment. Being part of this network provides important benefits for patients facing complex health issues when choosing a treatment center.

University Hospital Cologne

University Hospital Cologne is a strong contender when patients are asked about the best cancer hospital in Germany. Mainly because its oncology is organized around the Center for Integrated Oncology (CIO). The facility treats more than 25,000 patients annually and serves as the primary entry point for most oncology care at the hospital.<ref>20</ref>

The facility hosts interdisciplinary tumor boards in which all relevant specialties collaborate on diagnosis and treatment.<ref>21</ref> This structure is ideal for achieving precision oncology. It has been certified as an Oncological Center by the German Cancer Society since 2013 and boasts a notably extensive portfolio of 30 certified centers.<ref>22</ref>

Cologne has received international accreditation, particularly for its oncology units, including the pancreatic cancer center, which is certified under both DKG requirements and ISO 9001.<ref>23</ref> This certification reflects audited processes and a commitment to continuous quality checks.

Furthermore, the University Hospital Cologne features a strong infrastructure for clinical trials.<ref>24</ref> The Clinical Trials Centre Cologne maintains a public list of publications related to these trials, showcasing ongoing research collaborations that span from study support to publication.<ref>24</ref>

University Hospital Rechts der Isar Munich

University Hospital Rechts der Isar in Munich is frequently shortlisted by patients as the best cancer hospital in Germany, especially when cancer surgery is a key part of the plan. For international patients, the appeal is straightforward: complex cancer surgery is typically safest and most predictable at certified oncology centers, where decisions are made by multidisciplinary tumor boards rather than in isolated departments.<ref>2</ref>

At the University Hospital Rechts der Isar, the Comprehensive Cancer Center Munich features 14 certified organ centers.<ref>26</ref> These centers make up the oncology unit. Regular tumor conferences are held here to support management decisions across specialties.

A recent peer-reviewed study from the surgical department highlights effective treatment for pancreatic ductal adenocarcinoma. This analysis looked at 259 patients diagnosed with the condition between 2007 and 2021. The patients were classified as either borderline resectable or locally advanced. The study provided detailed insights into tumor resection, which often included vascular resection. This research was conducted at a high-volume center specializing in pancreatic surgery.<ref>27</ref>

If you or a loved one is facing the challenge of cancer surgery, consider the advantages of a high-volume center and the peace of mind it may bring.

{{ btn-select-the-proper-clinic__language=en&variant=2 }}

Which Clinics are Ranked in Positions 5–10?

This section completes the list by showcasing the clinics ranked 5–10. While they may not sit at the very top of the list, many are university hospitals with reliable specialist teams and comprehensive cancer centers. Explore more German-based cancer care hospitals below.

University Hospital Essen

University Hospital Essen is a major cancer destination in Germany because its cancer care is organized through the West German Cancer Center (WTZ).<ref>28</ref> In Essen alone, several hundred doctors and scientists from around 40 clinics and institutes collaborate on interdisciplinary cancer programs, so treatment plans are tailored to the tumor type and the patient.<ref>29</ref>

In the WTZ annual reporting, the facility lists 36,800 cancer patients overall, including 15,400 newly diagnosed cases, with 14,900 cancer inpatients and 33,800 cancer outpatients.<ref>30</ref> This level of throughput typically entails deeper subspecialization and more routine care for rare and complex tumors.

It also notes that University Hospital Essen allocated 8 new professorships to the translational center and lists research divisions in thoracic and visceral oncology, skin cancer, neuro-oncology, and pediatric neuro-oncogenomics.<ref>31</ref>

On top of that, Essen co-leads NCT West with Cologne and DKFZ support. They are focused on clinical trial structures and precision diagnostics across major cancer programs like lung cancer, leukemias and lymphomas, digestive tract tumors, prostate cancer, familial breast and ovarian cancer, and skin cancer, with rare tumors like sarcomas and eye tumors included too.<ref>32</ref>

Radiation oncology is another reason Essen is seen as top-tier. The West German Proton Therapy Center Essen reports treating over 5,000 patients with proton therapy, with children accounting for more than half.<ref>33</ref> For patients, this means advanced radiation can be planned alongside medical oncology and surgery in one coordinated system, which is exactly what you want in complex cancer care.

University Hospital Hamburg-Eppendorf

University Hospital Hamburg-Eppendorf (UKE) is often cited as the best cancer hospital in Germany, as its cancer care is concentrated at the Hubertus Wald Tumor Center, also known as the University Cancer Center Hamburg (UCCH).<ref>34</ref> UCCH treats more than 20,000 cancer patients every year, so the teams see a high volume of complex cases and rare tumors, not only the common ones.<ref>35</ref>

UKE stands out by organizing cancer treatment into specialized programs for various organs under one umbrella. UCC Hamburg features dedicated centers for breast cancer, gynecologic cancers, hematologic malignancies, and visceral cancers, including colorectal and pancreatic cancer.<ref>36</ref>

Additionally, it has programs for uro-oncology, pediatric oncology, sarcomas, and skin malignancies. The center also includes a Familial Breast and Ovarian Cancer Center and a Center for Personalized Medicine in Oncology. This structure promotes focused expertise while ensuring that planning remains integrated across different disciplines.

Another reason University Hospital Hamburg-Eppendorf is considered top-tier is its access to clinical trials and early therapies.<ref>37</ref> The hospital reports that its clinical trials office administers more than 70 trials, primarily interventional, with a focus on leukemia and gastrointestinal tumors.<ref>38</ref>

University Hospital Freiburg

University Hospital Freiburg is recognized as a top cancer center in Germany, and its care is supported by the Comprehensive Cancer Center Freiburg (CCCF).<ref>41</ref> The facility has been awarded the “Oncological Center of Excellence” designation by German Cancer Aid for the fifth time.<ref>39</ref>

The Comprehensive Cancer Center Freiburg connects 37 clinics, institutes, and facilities within the University Medical Center Freiburg. It operates 28 tumor boards that allow multiple specialists to collaboratively review complex cases.<ref>39</ref> This collaborative setup is crucial in oncology, as it minimizes gaps between diagnosis, staging, and therapy initiation, particularly when surgery, systemic therapy, and radiotherapy need to be coordinated.

Freiburg also stands out in high-intensity cancer treatments, especially for blood cancers. Its hematology, oncology, and stem cell transplantation service reports more than 10,000 oncology patients per year. It has 104 beds. It also reports about 25,000 chemotherapies per year and more than 200 bone marrow or stem cell transplants per year.<ref>40</ref> These figures point to deep routine with complex regimens and side-effect management, which is a big part of real-world cancer outcomes.

University Hospital Frankfurt am Main

University Hospital Frankfurt am Main is often named as the best hospital in Germany for cancer, and its oncology service is organized through the University Center for Tumour Diseases (UCT).<ref>42</ref> UCT coordinates interdisciplinary cancer care across three locations and convenes structured tumor boards in which specialists agree on a single plan for each case.<ref>43</ref><ref>44</ref>

University Hospital Frankfurt stands out for its precision oncology and access to targeted therapy through research and trials.<ref>45</ref> UCT reports conducting more than 350 Phase I to Phase III oncology clinical trials each year.<ref>46</ref> In its research-focused trial portfolio, UCT also highlights testing targeted molecular therapies in hematological diseases, gastric cancer, and other molecularly defined cancer groups. This is the practical side of “personalized cancer medicine,” where treatment choices can be guided by tumor biology and trial availability, rather than solely by standard protocols.

A clear distinguishing feature in Frankfurt is the interventional radiology unit, which offers interventional oncology services.<ref>47</ref> It gives patients minimally invasive options alongside systemic therapy. The unit lists dedicated oncological interventions, including microwave ablation, radiofrequency tumor ablation, selective internal radiation therapy, and transpulmonary chemoembolisation.

Hannover Medical School Hospital

People searching for the best cancer hospital in Germany often end up at Hannover Medical School (MHH). The oncological center here is the Comprehensive Cancer Center Hannover, also known as the Claudia von Schilling Center, and it operates within a Lower Saxony network with Göttingen.<ref>48</ref> German Cancer Aid named this joint center an Oncology Center of Excellence.<ref>49</ref>

What makes Hannover feel “top level” is how clearly the workload and specialization show up in the numbers. In 2023, the center treated 12,215 cancer patients. The report lists major tumor groups treated at high volume in 2023, including 1,261 breast cancer patients, 832 lung cancer patients, 774 leukemia patients, and 985 prostate cancer cases.<ref>50</ref>

MHH is making significant strides in precision oncology by focusing on real-world clinical decision-making rather than on publishing research papers alone. According to the CCC report, they've set up a Molecular Tumor Board and a Center for Personalized Medicine.<ref>51</ref> These initiatives help doctors select the most appropriate therapies based on molecular diagnostics. It's all about ensuring the right patient receives the right medication.

What's even more exciting is that this work is part of the German Network for Personalized Medicine.<ref>52</ref> This network is a collaboration of 21 sites focused on standardizing and expanding access to advanced testing and treatment options.<ref>53</ref>

{{ btn-choose-a-clinic__language=en&variant=2 }}

Ranking Methodology

To develop an unbiased ranking of the best cancer hospitals in Germany, Airomedical uses a multi-factor model that blends objective performance data with trusted user signals and expert reviews. Each hospital’s final position is a composite, normalized score calculated from the five core factors and additional minor metrics below. We routinely refresh, adjust, and apply safeguards to ensure data completeness and prevent gaming.

Clinics cannot pay to influence placement. Sponsored content, if any, is clearly labeled and kept separate from scoring. For full definitions, data sources, and factor-level math, consult the corresponding Help Centre pages.

Clinics must have a verifiable identity and provide sufficient data to be ranked. We reprocess inputs on a rolling basis and re-run the model when material updates occur (e.g., new certifications, primary outcomes releases).

All factors are placed on comparable scales and weighted to determine a cancer-specific clinic rating—emphasizing patient-important outcomes, safety, and validated care quality, while also reflecting access, transparency, and user experience. Ties are broken in the order of clinical outcomes, then safety, and finally, access. When data are incomplete, we use conservative estimates or omit the metric to avoid unfair bias; missing data never improve a hospital’s rank.

Core Metrics

Below is a brief overview of the core metrics that drive our rankings: AiroScore, UserScore, the Clinical Quality Dataset, External Rating Signals, and Editorial Verification. This section summarizes what each captures and how it fits into the composite score; it’s intentionally high-level. Technical deep-dives for each factor are available in our Help Centre.

Integrated AiroScore

AiroScore is our unified metric that combines verified hospital profile data, such as accreditation, scope of services, clinician and department strength, transparency in offerings, service quality, profile completeness, and freshness, with aggregated user-behavior signals to create a single, comparable score. It is worth noting that UserScore (below) is one of AiroScore’s sub-components; however, AiroScore also captures broader institutional strength and service readiness. Inputs are standardized to comparable scales, weighted by demonstrated impact on outcomes and patient decision-making, then aggregated into a single score.

Experience Quality via UserScore

UserScore evaluates the credibility and substance of user feedback - not just star averages. Each review is assigned a TrustScore based on the integrity of its source, reviewer signals, and the quality of its content. We also model credibility over time (periodicity and history), reviewer diversity, case complexity, review volume and recency, and textual specificity (e.g., mentions of care coordination, nursing, discharge, digital touchpoints). The result is a robust user-experience measure that resists outliers and fake or low-information reviews.

Comprehensive Statistical Clinical Quality Dataset

This factor summarizes risk-adjusted clinical performance and operational reliability, as reported by trusted statistical sources. It spans outcomes and patient safety, experience and access, workforce and efficiency, education and innovation, technology/data compliance, and key specialty process checks. Metrics are normalized and, where relevant, case-mix adjusted, then rolled into a single clinical-quality subscore.

External Rating Signals

We incorporate calibrated signals from reputable third-party rankings to improve coverage and triangulate areas our model may not directly observe. External inputs are deduplicated, mapped to standard definitions, downweighted if their methodologies overlap with ours, and time-decayed so that fresher, higher-quality signals exert more influence. This adds breadth without letting any single external list dominate.

Editorial Verification

Before publication, our editorial team conducts manual checks to verify identities, resolve data discrepancies, confirm unusual values, and review borderline rank changes. Editors verify critical details (e.g., certification status, service availability) and approve the final list to minimize technical errors. Human oversight remains an essential safeguard.

Additional Factors

To ensure the list reflects the cancer care landscape in Germany, we also review each hospital’s primary focus and specialty coverage within the Airomedical tag-based system. This does not reward or penalize the clinic itself; it helps avoid overconcentration and ensures the final selection serves the varied needs of patients.

FAQ

<faq>Whis if the best cancer hospital in Germany? According to our ranking, University Hospital Charité Berlin, with its Charité Comprehensive Cancer Center, is positioned as the top hospital.

Do I need a referral to get cancer treatment in Germany? Usually, no, for self-paying, private international patients. You can request a remote medical review and receive a proposed treatment plan before traveling.

How do I choose the right hospital from the list? Match the hospital to your cancer type and required modality: complex surgery centers for rare tumors, high-end radiation centers for precise radiotherapy, and university cancer centers for clinical trials and multidisciplinary tumor boards. Additionally, pay attention to the review section, the Airomedical scoring system, and the tag-based primary focus.

Can I get a second opinion from Germany without traveling? Yes. Many leading oncology hospitals provide remote second opinions based on your medical files and imaging.

Are German cancer hospitals known for specific cancers? Yes. Some centers are particularly strong in areas like breast cancer, prostate cancer, lung cancer, colorectal cancer, brain tumors, leukemia/lymphoma, sarcoma, and pediatric oncology, often within specialized organ tumor centers.

What is a “tumor board” and why does it matter? A tumor board is a multidisciplinary meeting (oncology, surgery, radiology, pathology, radiation oncology) that reviews your case and agrees on the best course of action. In leading German centers, tumor board decisions improve coordination and reduce delays.

Do German hospitals provide treatment in English? Many do. Especially university hospitals and international departments. If not, hospitals can often arrange professional medical interpreters.

How do German hospitals ensure quality and safety in oncology? Top centers typically adhere to evidence-based guidelines, operate certified organ cancer centers, track outcomes, and employ multidisciplinary case review, particularly in university-affiliated programs.

Are German cancer hospitals good for rare cancers? Often yes. Rare cancers benefit from high-volume university centers with subspecialists, molecular tumor boards, and access to clinical trials.</faq>

References

German Cancer Society (Deutsche Krebsgesellschaft). German Cancer Society. Retrieved January 2026.
European Cancer Centre Certification Programme. Certification System. Retrieved January 2026.
Charité Comprehensive Cancer Center (CCCC) – Charité – Universitätsmedizin Berlin. About us. Retrieved January 2026.
Charité Comprehensive Cancer Center (CCCC) – Charité – Universitätsmedizin Berlin. Interdisciplinary Tumor Boards. Retrieved January 2026.
Boos, L., & Wicki, A. (2024, April 30). The molecular tumor board—a key element of precision oncology. memo - Magazine of European Medical Oncology, 17, 190–193. doi:10.1007/s12254-024-00977-7. Retrieved January 2026.
Charité Comprehensive Cancer Center (CCCC) – Charité – Universitätsmedizin Berlin. CCCC Services. Retrieved January 2026.
BerlinProtonen – Charité – Universitätsmedizin Berlin. BerlinProtonen: proton therapy of eye tumors at the Charité. Retrieved January 2026.
Höcht, S., Bechrakis, N. E., Nausner, M., Kreusel, K.-M., Kluge, H., Heese, J., et al. (2004, July). Proton Therapy of Uveal Melanomas in Berlin: 5 Years of experience at the Hahn-Meitner Institute. Strahlentherapie und Onkologie, 180(7), 419–424. doi:10.1007/s00066-004-1222-5. Retrieved January 2026.
Heidelberg University Hospital – International Patients. National Center for Tumor Diseases (NCT) Heidelberg. Retrieved January 2026.
German Cancer Research Center (DKFZ). National Center for Tumor Diseases (NCT). Retrieved January 2026.
National Center for Tumor Diseases (NCT) Heidelberg. NCT Heidelberg – Facts and Figures. Retrieved January 2026.
National Center for Tumor Diseases (NCT) Heidelberg. NCT Heidelberg – Onkologisches Spitzenzentrum der Deutschen Krebshilfe. Retrieved January 2026.
National Center for Tumor Diseases (NCT) Heidelberg. Immunotherapy. Retrieved January 2026.
CCC München – Comprehensive Cancer Center. CCC München - Comprehensive Cancer Center. Retrieved January 2026.
CCC-Netzwerk der Deutschen Krebshilfe. Onkologische Spitzenzentren. Retrieved January 2026.
Heinrich, K., Miller-Phillips, L., Ziemann, F., Hasselmann, K., Rühlmann, K., Flach, M., Biro, D., von Bergwelt-Baildon, M., Holch, J., Herold, T., von Baumgarten, L., Greif, P. A., Jeremias, I., Wuerstlein, R., Casuscelli, J., Spitzweg, C., Seidensticker, M., Corradini, S., Jung, A., Kirchner, T., Heinemann, V., & Westphalen, C. B. (2022, July 7). Lessons learned: the first consecutive 1000 patients of the CCCMunich LMU Molecular Tumor Board. Journal of Cancer Research and Clinical Oncology, 149, 1905–1915. doi:10.1007/s00432-022-04165-0. Retrieved January 2026.
LMU Klinikum – Krebszentrum (CCC Münchenᴸᴹᵁ). Klinische Studien. Retrieved January 2026.
LMU Klinikum – Krebszentrum (CCC Münchenᴸᴹᵁ). Early Clinical Trial Unit (ECTU). Retrieved January 2026.
German Cancer Consortium (DKTK). Munich. Retrieved January 2026.
Centrum für Integrierte Onkologie (CIO) Köln – Uniklinik Köln. Centrum für Integrierte Onkologie (CIO) Köln. Retrieved January 2026.
Centrum für Integrierte Onkologie (CIO) Köln – Uniklinik Köln. Tumorboards - Interdisziplinäre Fallkonferenzen im CIO. Retrieved January 2026.
Centrum für Integrierte Onkologie (CIO) Köln – Uniklinik Köln. Krebszentren im CIO Köln. Retrieved January 2026.
University Hospital Cologne (Uniklinik Köln), Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Transplantationschirurgie. Zertifizierte Qualität. Retrieved January 2026.
Clinical Trials Centre Cologne (ZKS Köln). Clinical Trials Centre Cologne. Retrieved January 2026.
Clinical Trials Centre Cologne (ZKS Köln). Publications. Retrieved January 2026.
Comprehensive Cancer Center München (CCC München TUM), TUM Klinikum Rechts der Isar. Onkologisches Zentrum/Organtumorzentren. Retrieved January 2026.
Ren, L., Jäger, C., Schorn, S., Pergolini, I., Göß, R., Safak, O., et al. (2023, June 28). Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center. Annals of Surgery Open, 4(3), e302. doi:10.1097/AS9.0000000000000302. Retrieved January 2026.
University Medicine Essen. Universitätsmedizin im Portrait: Weltweit gefragte Kompetenz und Spitzenmedizin. Retrieved January 2026.
Universität Duisburg-Essen, Medizinische Fakultät. Schwerpunkt: Onkologie. Retrieved January 2026.
West German Cancer Center Consortium (WTZ Consortium). (2022). Shaping the future together: Annual Report 2022 (PDF). Retrieved January 2026.
German Cancer Consortium (DKTK). Essen/Düsseldorf. Retrieved January 2026.
National Center for Tumor Diseases (NCT). NCT West. Retrieved January 2026.
Westdeutsches Protonentherapiezentrum Essen (WPE). The WPE. Retrieved January 2026.
University Medical Center Hamburg-Eppendorf (UKE). UCC Hamburg. Retrieved January 2026.
University Medical Center Hamburg-Eppendorf (UKE). The UCC Hamburg. Retrieved January 2026.
University Medical Center Hamburg-Eppendorf (UKE). Organ Cancer Centers. Retrieved January 2026.
University Medical Center Hamburg-Eppendorf (UKE). Study participation. Retrieved January 2026.
University Medical Center Hamburg-Eppendorf (UKE), II. Medical Clinic and Polyclinic. Clinical Trials Office: Portfolio. Retrieved January 2026.
University Medical Center Freiburg. Freiburg Tumor Center remains an oncology center of excellence. Retrieved January 2026.
University Medical Center Freiburg, Department of Internal Medicine I. Hematology, Oncology and Stem Cell Transplantation. Retrieved January 2026.
Comprehensive Cancer Center Freiburg (CCCF) – University Medical Center Freiburg. Oncological Center of Excellence. Retrieved January 2026.
UCT Frankfurt-Marburg. Our patients in focus. Retrieved January 2026.
UCT Frankfurt-Marburg. The UCT Frankfurt-Marburg. Retrieved January 2026.
UCT Frankfurt-Marburg. Tumor Boards. Retrieved January 2026.
UCT Frankfurt. Our Precision Oncology Mission. Retrieved January 2026.
UCT Frankfurt-Marburg. Clinical Trials. Retrieved January 2026.
Frankfurt University Hospital, Clinic for Radiology and Nuclear Medicine. Clinic for Radiology and Nuclear Medicine at Frankfurt University Hospital. Retrieved January 2026.
Hannover Medical School (MHH). Claudia von Schilling-Center. Retrieved January 2026.
Hannover Medical School (MHH). (2021, February 3). CCC Lower Saxony honored as Oncology Center of Excellence. Retrieved January 2026.
Comprehensive Cancer Center (CCC) Hannover, Claudia von Schilling-Zentrum, Medizinische Hochschule Hannover (MHH). (2024, November). Bericht 2023: Jahresbericht (Kennzahlenjahr 2023) (PDF). Retrieved January 2026.
Hannover Medical School (MHH), Claudia von Schilling-Center. Molecular tumor board. Retrieved January 2026.
European Cancer Centre Certification Programme (ECC). DNPM: German Network for Personalised Medicine. Retrieved January 2026.
G-BA Innovationsfonds. (2025, February 12). Ein Netzwerk im Kampf gegen Krebs. Retrieved January 2026.

</reflinks>

Rankings